Baseline Laboratory Testing Before Medication Initiation Before starting medication, many patients undergo baseline laboratory testing to assess metabolic status, confirm safety, and establish a reference point for long-term monitoring
and international insurance coverage policies that consider both the clinical benefits of GLP-1 drugs and the economic realities of varying health care systems
Moreover, ongoing research suggests that liraglutide may slightly increase the risk of certain cancers, such as pancreatic, breast, and thyroid cancer [23]
2013;28(Suppl 4):iV82-98
Rahmanian argues that keeping the creative internal was essential for authenticity
They concluded that incretin-based medications did not correlate with an increased risk of acute pancreatitis or pancreatic cancer compared to other oral anti-diabetic agents, which remained consistent across drug classification and duration of use [29,55]